QDEL · NASDAQ
QuidelOrtho (QDEL) Stock Price & Fundamentals
QuidelOrtho (QDEL) closed at $433.60 on Oct 9, 2026, down 0.59% from the previous close of $436.18.
Share price, past year
1Y +17.94%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $433.60 |
| Sep 30, 2026 | $442.32 |
| Aug 31, 2026 | $433.39 |
| Jul 31, 2026 | $436.81 |
| Jun 30, 2026 | $416.27 |
| May 29, 2026 | $394.49 |
| Apr 30, 2026 | $378.33 |
| Mar 31, 2026 | $366.83 |
| Feb 27, 2026 | $379.35 |
| Jan 30, 2026 | $387.98 |
| Dec 31, 2025 | $364.48 |
| Nov 28, 2025 | $381.02 |
| Oct 31, 2025 | $365.31 |
Key statistics
- Market cap
- $29.61B
- P/E (TTM)
- —
- EPS (TTM)
- −$15.44
- Revenue (TTM)
- $2.67B
- Net income (TTM)
- −$1.05B
- Shares outstanding
- 68.3M
- Dividend yield
- —
- 52-week range
- $351.77 – $447.29
QuidelOrtho's market cap is $29.61B, based on a share price of $433.60 and 68.3M shares outstanding as of Jun 28, 2026.
Financials
QuidelOrtho reported revenue of $2.73B for fiscal 2025, down 1.89% from fiscal 2024.
QuidelOrtho reported a net loss of $1.13B in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 28, 2025 | $2.73B | −1.9% | −$1.13B | −41.5% | −$16.69 | −$83.00M |
| FY2024ended Dec 29, 2024 | $2.78B | −7.2% | −$2.05B | −73.7% | −$30.54 | −$112.10M |
| FY2023ended Dec 31, 2023 | $3.00B | −8.2% | −$10.10M | −0.3% | −$0.15 | $70.90M |
| FY2022ended Jan 1, 2023 | $3.27B | +92.3% | $548.70M | 16.8% | $9.56 | $744.40M |
| FY2022ended Jan 2, 2022 | $1.70B | +2.2% | $548.70M | 32.3% | $9.56 | $744.40M |
| FY2021ended Jan 3, 2021 | $1.66B | — | $810.30M | 48.8% | $18.60 | $564.80M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 28, 2026 | $630.90M | −$92.90M | −$1.36 |
| Q1 FY2026ended Mar 29, 2026 | $619.80M | −$91.80M | −$1.35 |
| Q4 FY2025ended Dec 28, 2025 | $723.60M | −$130.70M | −$1.95 |
| Q3 FY2025ended Sep 28, 2025 | $699.90M | −$733.00M | −$10.78 |
| Q2 FY2025ended Jun 29, 2025 | $613.90M | −$255.40M | −$3.77 |
| Q1 FY2025ended Mar 30, 2025 | $692.80M | −$12.70M | −$0.19 |
| Q4 FY2024ended Dec 29, 2024 | $707.80M | −$178.40M | −$2.54 |
| Q3 FY2024ended Sep 29, 2024 | $727.10M | −$19.90M | −$0.30 |
Company profile
- Name
- QuidelOrtho Corp
- Ticker
- QDEL
- Exchange
- NASDAQ
- Industry (SEC SIC)
- In Vitro & In Vivo Diagnostic Substances
- Headquarters
- 9975 Summers Ridge Road, San Diego, CA 92121
- Fiscal year ends
- January
- SEC CIK
- 0001906324
Recent SEC filings
- Sep 23, 2026
- Aug 7, 2026
- Aug 6, 2026
- Jun 23, 2026
- Jun 16, 2026
- May 6, 2026
- May 5, 2026
- Apr 15, 2026
Frequently asked questions
What is QuidelOrtho's stock price?
QuidelOrtho (QDEL) closed at $433.60 on Oct 9, 2026, down 0.59% from the previous close of $436.18.
What is QuidelOrtho's market cap?
QuidelOrtho's market cap is $29.61B, based on a share price of $433.60 and 68.3M shares outstanding as of Jun 28, 2026.
How much revenue does QuidelOrtho make?
QuidelOrtho reported revenue of $2.73B for fiscal 2025, down 1.89% from fiscal 2024.
Does QuidelOrtho pay a dividend?
QuidelOrtho's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from QuidelOrtho Corp's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures